v3 Chapter 759： Chattering

Among the three groups, Xia Yu was responsible for conquering the Coller Perkins company, which has the strongest relationship with Professor Herb Boyle.

Although Coller Perkins invested in Genentech three times and seemed to have always supported Professor Herb Boyle, Xia Yu didn't care.

Weak strength is the Achilles heel of Coller Perkins. Venture capital companies like it generally cast angel rounds or round A, and being able to follow round B is already the limit.

Genentech was pushed to go public and is no longer in Series C financing. It might not be possible that they will help fuel the flames.

For example, Genentech’s valuation is more than 100 million at this time. If a C round of financing is opened, a 10% stake will require at least US$10 million or more.

With the strength of Coller Perkins, it is difficult to keep up. After all, their company’s operational capital does not exceed US$50 million, and it is impossible to invest only in Genentech’s project, so the company’s liquidity will never many.

Genentech’s valuation is already high enough. It’s the best way to go public and let the public capital take risks. Coller Perkins can also profit from the arbitrage and use the huge profits to invest in new seedlings. The enterprise grows in this cycle.

Because they had made an appointment in advance, Xia Yu and others were led by the receptionist and met Harry Morrison, CEO of Coller Perkins, and two other executives.

Seeing Xia Yu's team of five people, but with a young yellow race as the core, Harry Morrison's eyes condensed, and several thoughts flashed in his mind.

Regarding Polaris Capital, Harry Morrison had never heard of it before, that is, when he got an appointment yesterday, he specifically inquired about it, and received not much news, except that it was a newly established company.

But he does not doubt the strength of Polaris Capital, because according to his investigation, Polaris Capital bought a 30-story office building in downtown San Francisco as soon as it arrived.

Anyway, with the strength of their Coller Perkins company, there is absolutely no spare money to buy an office building!

Therefore, he holds a cautious or even vigilant attitude towards Polaris Capital, whose purpose is unknown.

For a company with a mysterious background, it is best not to offend it!

Harry Morrison did not show his true attitude. He enthusiastically greeted Xia Yu and others to take their seats. After his subordinates poured tea and coffee for everyone, he drank coffee and chatted with Xia Yu.

"Mr. Xia, it's an honor to meet you and welcome your visit!"

"Thank you Mr. Morrison for your warm hospitality!"

...

"Mr. Xia, I wonder if you are here this time, what can I do for you?" After the greeting, Harry Morrison asked, looking at Xia Yu tightly.

Xia Yu smiled slightly and said, "I'm here to bother this time, mainly because I want to do your company a favor. Of course, I'm telling the truth and it's good for us. It's a win-win thing."

Harry Morrison couldn't comment, but he became more vigilant in his heart. He didn't believe there was such a good thing. He then asked: "I don't know what it is?"

Xia Yu smiled and said bluntly: "In fact, I want to buy the equity of Genentech held by your company."

Harry Morrison's face changed suddenly, and before he spoke, a middle-aged white man in his thirties next to him resolutely said: "Impossible, the equity of Genentech is not for sale in our company!"

Seeing the people next to him say it, Harry Morrison's expression became a little more relaxed, but his tone was also cold, as if leaving no room for him, he refused: "I'm sorry, Mr. Xia, we can't meet your request!"

Xia Yu stopped the subordinates who wanted to talk, looked calm, smiled and looked at the person who spoke first, and asked: "Sir, can I be lucky enough to know your name?"

Xia Yu's attitude is very friendly, so the middle-aged white man's face also eased, and he uttered a few words: "Robert Swanson!"

Xia Yu suddenly understood that it was the one who discovered Genentech. No wonder the reaction was so intense.

With his achievements in discovering Genentech, it is normal to become a senior partner of Coller Perkins. No wonder he can accompany Harry Morrison.

Xia Yu said with a smile: "Mr. Swanson, and Mr. Morrison, in fact, you don’t have to refuse so fast. There is nothing in the world that cannot be sold. The key is whether the price can be satisfied or not. I have not yet bid. Why should you refuse so fast?"

"Maybe my price will satisfy you?"

Harry Morrison and Robert Swanson looked at each other, and both saw the surprise in each other's eyes.

After making eye contact between Robert Swanson and Harry Morrison, he said indifferently: "Mr. Xia, Genentech is already in the process of going public, and it can be listed in at most six months. By then, its market value will definitely be better than The current valuation is several times higher, why should we pick the fruits in advance?"

Xia Yu shook his head and retorted: "It is difficult to say whether it is several times higher, because so far, Genentech has not made a profit. No one knows how the capital market will choose, maybe it will fall below the issue price?"

Robert Swanson is not a fuel-efficient lamp either. He directly caught Xia Yu’s painful foot and strongly retorted: “It will never fall below the issue price! Maybe I was not sure what the capital market would choose before, but you are here today. On the contrary, our confidence has been strengthened. I believe that Genentech will definitely be able to go public successfully, and the stock price has greatly exceeded the opening price!"

Well, this statement of Xia Yu was directly blocked by Robert Swanson.

However, Xia Yu had prepared well before he came, and the reasons for the negotiation had been thought out a lot.

He did not admit Robert Swanson’s statement, ignored it, opened another battlefield and said: "Mr. Swanson, if half a year, Genentech can be listed, but your original equity will be locked for one year before the transaction can be unlocked. , Which means that your funds will be locked in at least one and a half years, even if Genentech’s stock price is high, you will not be able to cash out."

"At the current speed of technological development, in this year and a half, there will be countless companies with extremely strong potential ~ www.novelhall.com~ Are you willing to miss it because of funding?"

Weak strength is the Achilles’ heel. If Coller Perkins is well-capitalized, Xia Yu’s reason is simply untenable.

But speaking out now makes Harry Morrison and Robert Swanson look ugly.

At this time, another middle-aged man Colin Hicks who had been sitting silently defended: “Mr. Xia, you don’t have to worry about this. We can afford to wait for half a year. Genentech goes public. Now, even if our original shares are locked, we can still use equity pledges to find bank loans."

"And I believe that as long as Genentech is listed, there will be a steady stream of investors waving U.S. dollars to us for investment."

Xia Yu said with a smile: "Is it hard to say whether there will be investors coming to the door? After all, it hasn't happened yet. I will just say one thing. You want to pledge the loan with Genentech's equity. The prerequisite is that Genentech is successfully listed."

"Then, you are also very aware of the conservativeness of the banks. They like the stocks of companies listed on the New York Stock Exchange. They do not approve of the NASDAQ stocks, otherwise the capital market of venture capital will not appear."

"Even if you find a bank that is willing to pledge loans, the loan ratio will be four or five tiers. After all, for banks, Nasdaq stocks with negative earnings and high stock prices are too risky."

"With so many risks, you still need to pay high interest rates to the bank. What will happen if Genentech's stock price plummets or you don't find new potential companies?"

The three of Xia Yu's statements were speechless, and they did not know how to refute them.

ps: Subscription book!

https://

Please remember the domain name of this book's first publication:. Apex novel mobile version reading URL: